Connect with us

Cannabis News

Legal Psychedelic Dispensaries for Psilocybin and Shrooms Launch in Colorado

Published

on


Colorado psychedelic markets launch

Colorado’s trailblazing journey toward the legalization of psychedelics has reached a significant turning point with the formal establishment of a complete set of laws for the state’s burgeoning psilocybin business. After nearly two years of meticulous planning, this regulatory framework allows businesses to engage in the manufacturing, distribution, and therapeutic use of mescaline, psilocin, ibogaine, DMT, and magic mushrooms as allowed by Proposition 122.

 

With this clearance, Colorado becomes one of the several states that acknowledge the possible medical advantages of psychedelics. The recently enacted regulations, as noted by the Green Market Report, provide a regulated operating environment for enterprises by outlining precise licensing processes for producers of products, therapy centres, and mushroom farmers.

 

These therapy clinics are critical to the emerging sector. They will provide participants with the opportunity to experience the effects of psychedelics while under the cautious observation of state-certified specialists. This structure is intended to assure both safety and efficacy, with tight guidelines in place to avoid overuse. Importantly, the sale of psychedelic compounds for home use is not permitted, and usage is limited to these supervised settings.

 

Governor Jared Polis has been an outspoken supporter of the new psychedelics legislation, praising Colorado’s natural medicine leadership in his State of the State address earlier this year. Polis praised Colorado’s heritage as the first state to legalize recreational cannabis, as well as its ongoing role in establishing national drug policy reform norms.

 

Expanding Product Options with Controlled Potency

 

The decision also specifies what kinds of products producers are permitted to sell. Apart from dehydrated psilocybin mushrooms, manufacturers are permitted to make a wide range of infused goods, such as tea bags, capsules, chocolates, gummies, tablets, and tinctures. This wide array of choices satisfies consumers’ increasing desire for non-traditional consumption methods that accommodate a variety of tastes and medical requirements.

 

However, the state has placed tight restrictions on these goods. Ten milligrams of psilocin, the primary hallucinogenic ingredient in magic mushrooms, are considered to be one serving. In its dried form, this is equivalent to around one gram per dosage. The legal limits for edibles allow for a maximum of 50 milligrams of psilocin or 5 milligrams of psilocybin mushrooms. The purpose of these restrictions is to regulate the potency of the substance and reduce the possibility of negative consequences.

 

Beyond product regulations, the new rules specify requirements for the physical locations of healing centers. These centers may be integrated into larger healthcare facilities or situated alongside mushroom grow sites or manufacturing plants. However, the regulations require that these operations be clearly separated within the facility to maintain distinct boundaries between different activities.

 

Pioneering Regulatory Standards for Psychedelics

 

For Colorado’s regulatory agencies, which have carefully weighed the possible advantages of psychedelics against worries about public safety, the adoption of these regulations represents a major turning point. This framework takes a cautious but progressive approach to integrating psychedelics into the healthcare system, and it is anticipated that other states considering legislation along these lines would use it as a model.

 

The top cannabis regulator in the state, Dominique Mendiola, reflected on the ten years that Colorado has gone without legalizing marijuana and noted how the state’s new psychedelics program is being developed using the lessons acquired from the legalization of marijuana. During this transformation, Mendiola is essential. He is the senior director of the newly formed Natural Medicine Division and the Marijuana Enforcement Division (MED).

 

“We’re leveraging the experience and lessons learned [from marijuana] to inform the process of establishing an entirely new program,” Mendiola explained during a podcast interview with Weed Wonks. Her approach emphasizes adaptability, a key principle that has been essential in managing the evolving landscape of cannabis regulation.

 

Tailoring Regulation: Lessons from Cannabis, Adapted for Psychedelics

 

While drawing on Colorado’s experience with marijuana regulation, Mendiola emphasized the differences between overseeing cannabis and psychedelics. “We’re not suggesting that we’ll just apply our marijuana rulebook here,” she clarified. The forthcoming psilocybin program, which will open its first round of business license applications by December 31, will operate under its own distinct guidelines. Unlike cannabis businesses, psilocybin enterprises will not sell psychedelics directly to consumers. Instead, the law requires the establishment of state-regulated psilocybin “healing centers,” where clients can use the substance in a supervised environment.

 

Mendiola stressed that this tailored approach is necessary because people use cannabis and psychedelics for different reasons, which means the psilocybin program is expected to be smaller in scale than Colorado’s extensive marijuana market.

 

One key lesson Mendiola brings from her experience in cannabis regulation is the importance of stakeholder engagement. The Natural Medicine Division has made it a priority to hold listening sessions and town halls across the state, encouraging public input on the new rules. “We have needed to be very deliberate about that when we engage in this work,” Mendiola noted, emphasizing the ongoing efforts to involve local jurisdictions and federally recognized tribes in these discussions.

 

Mendiola also pointed out that while the initial rules have been finalized, her office is ready to make adjustments if necessary. “Are we seeing issues that require emergency rulemaking? Are there gaps we didn’t anticipate that we need to address?” she asked, signaling a proactive approach to potential challenges

 

Bottom Line

 

Colorado’s new psilocybin industry represents a significant step in the state’s leadership in drug policy reform, building on its pioneering role in cannabis legalization. The state has developed a comprehensive regulatory framework under Proposition 122, allowing for the controlled manufacturing, distribution, and therapeutic use of psychedelics like psilocybin, mescaline, and DMT. This framework emphasizes safety and efficacy, with strict guidelines that limit usage to supervised settings in state-regulated “healing centers.”

The regulations also set clear standards for product potency, aiming to minimize risks associated with psychedelic use. Manufacturers are permitted to create a variety of infused products, but each comes with precise dosage limits to ensure consumer safety. By restricting sales for home use and focusing on therapeutic environments, Colorado seeks to balance access to potential medical benefits with public safety concerns.

As other states consider similar legislation, Colorado’s approach, which includes extensive stakeholder engagement and adaptability in rulemaking, is likely to serve as a model. This cautious yet forward-thinking strategy underscores the state’s commitment to integrating psychedelics into healthcare responsibly, setting the stage for a new era in natural medicine.

 

HOW COLORADO LEGALIZED MAGIC MUSHROOMS, READ ON…

COLORADO NATURAL MEDICINE ACT

COLORADO’S NATURAL MEDICINE ACT LEGALIZE SHROOMS?



Source link

Cannabis News

Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It

Published

on

By


trump on marijuana reform

In a recent interview, former New Jersey Governor Chris Christie made headlines by asserting that President-elect Donald Trump will pursue significant reforms in federal policies regarding marijuana and cryptocurrency. As the nation grapples with evolving attitudes toward cannabis and the burgeoning digital currency market, Christie’s predictions have ignited discussions about the potential implications of such changes on both industries. This article delves into Christie’s insights, the current state of marijuana and cryptocurrency regulations, and the broader implications of these anticipated reforms.

 

The Current Landscape of Marijuana Legislation

 

Federal vs. State Laws

Marijuana remains classified as a Schedule I substance under the Controlled Substances Act (CSA), which places it in the same category as heroin and LSD. This classification has created a complex legal landscape where states have moved to legalize cannabis for medical and recreational use, while federal law continues to impose strict prohibitions. As of now, over 30 states have legalized marijuana in some form, leading to a burgeoning industry that generates billions in revenue.

 

Challenges Faced by the Cannabis Industry

 

Despite its legality in many states, the cannabis industry faces significant hurdles due to federal restrictions. These challenges include:

  • Banking Access: Many banks are hesitant to work with cannabis businesses due to fear of federal repercussions, forcing these businesses to operate largely in cash.

  • Taxation Issues: The IRS enforces Section 280E of the tax code, which prohibits businesses engaged in illegal activities from deducting normal business expenses, leading to disproportionately high tax burdens for cannabis companies.

  • Interstate Commerce: The lack of federal legalization prevents cannabis businesses from operating across state lines, limiting their growth potential.

 

Chris Christie’s Perspective on Marijuana Reform

 

Christie, a former presidential candidate known for his tough stance on drugs during his tenure as governor, has evolved his views on marijuana over the years. In his recent statements, he emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from the Schedule I classification. This move would not only provide clarity for businesses operating in legal markets but also open avenues for banking and investment.

 

Christie highlighted that descheduling would allow for a more regulated market where safety standards could be established, thus protecting consumers. He believes that this approach aligns with a growing consensus among Americans who support legalization and recognize the potential benefits of cannabis use for both medical and recreational purposes.

 

The Future of Cryptocurrency Regulation = The Rise of Cryptocurrencies

 

Cryptocurrencies have surged in popularity over the past decade, with Bitcoin leading the charge as the first decentralized digital currency. The market has expanded to include thousands of alternative coins (altcoins), each with unique features and use cases. As cryptocurrencies gain traction among investors and consumers alike, regulatory scrutiny has intensified.

 

Current Regulatory Challenges

 

The cryptocurrency market faces several regulatory challenges that hinder its growth and adoption:

 

  • Lack of Clarity: Regulatory frameworks vary significantly across states and countries, creating confusion for investors and businesses.

  • Fraud and Scams: The rapid growth of cryptocurrencies has led to an increase in fraudulent schemes targeting unsuspecting investors.

  • Consumer Protection: Without clear regulations, consumers are often left vulnerable to risks associated with volatile markets.

 

Christie’s Vision for Crypto Regulation

 

Christie believes that under Trump’s leadership, there will be an effort to find a “sweet spot” for cryptocurrency regulation balancing innovation with consumer protection. He argues that overly stringent regulations could stifle growth in this emerging sector while too little oversight could expose consumers to significant risks.

 

In his view, a balanced regulatory framework would include:

 

1. Clear Definitions: Establishing clear definitions for different types of cryptocurrencies and tokens to differentiate between securities and utility tokens.

2. Consumer Protections: Implementing measures to protect investors from fraud while promoting transparency within the market.

3. Encouraging Innovation: Creating an environment conducive to innovation by allowing startups to thrive without excessive regulatory burdens.

 

Christie’s insights reflect a growing recognition among policymakers that cryptocurrencies are here to stay and that appropriate regulations are necessary to foster growth while safeguarding consumers.

 

Implications of Proposed Reforms

 

Economic Impact

 

The potential reforms proposed by Christie could have far-reaching economic implications:

 

  • Job Creation: Legalizing marijuana at the federal level could lead to significant job creation within the cannabis industry—from cultivation and production to retail sales.

  • Investment Opportunities: Descheduling cannabis would open up investment opportunities for institutional investors who have been hesitant due to federal restrictions.

  • Boosting Local Economies: Legal cannabis markets have proven beneficial for local economies through increased tax revenues and job creation.

 

Similarly, clear regulations around cryptocurrencies could stimulate investment in blockchain technology and related industries, fostering innovation and economic growth.

 

Social Justice Considerations

 

Both marijuana legalization and sensible cryptocurrency regulations have social justice implications:

 

  • Addressing Past Injustices: Legalizing marijuana could help rectify past injustices related to drug enforcement policies that disproportionately affected marginalized communities.

  • Financial Inclusion: Cryptocurrencies offer opportunities for financial inclusion for those underserved by traditional banking systems, particularly in low-income communities.

 

Political Landscape

 

The political landscape surrounding these issues is complex. While there is bipartisan support for marijuana reform among certain lawmakers, challenges remain in overcoming entrenched opposition. Similarly, cryptocurrency regulation has garnered attention from both sides of the aisle but requires collaboration to establish effective frameworks.

 

Conclusion

 

Chris Christie’s predictions about President-elect Donald Trump’s approach to federal marijuana descheduling and cryptocurrency regulation suggest a potential shift in U.S. policy that could significantly reshape both industries. As public opinion evolves on these issues, lawmakers have an opportunity to enact meaningful reforms that promote economic growth while ensuring consumer protection. The anticipated changes could foster a more robust cannabis industry that contributes positively to the economy and addresses social justice concerns, while clear regulatory frameworks for cryptocurrencies could encourage innovation and protect consumers in the digital economy. Stakeholders in both sectors are closely watching these developments, eager to see how potential reforms might impact their futures. While the realization of Christie’s predictions remains uncertain, it’s clear that the conversation around marijuana and cryptocurrency regulation is ongoing and far from settled.

 

TRUMP 2.0 ON CANNABIS REFORM, READ ON…

TRUMP ON MARIJUANA REFORM

TRUMP 2.0 ON FEDERAL CANNABIS REFORM – WHAT DO WE KNOW?

 



Source link

Continue Reading

Cannabis News

Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em

Published

on

By


On Thursday, November 7th, Vince Sliwoski, Aaron Pelley and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay!

Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar:

  1. Panelists:
    • Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial real estate.
    • Aaron Pelley: Experienced in cannabis law since Washington’s legalization in 2012.
    • Fred Rocafort: Trademark attorney working closely with the cannabis team.
  2. Election Results Overview:
    • Most 2024 cannabis ballot measures did not pass.
    • Florida, South Dakota, and North Dakota saw failures.
    • Nebraska became the 39th state to legalize cannabis for medical use when it passed two cannabis initiatives, Initiatives 437 and 438.
  3. Federal and State-Level Developments:
    • Medical use is currently legal in 38 states, and 24 states allow recreational use.
    • Republican support for marijuana legalization is growing.
  4. Federal Policy Implications:
    • Schedule III Rescheduling: The process to move cannabis to Schedule III is ongoing, which could significantly impact the industry.
    • Importance of Federal Appointments: The future of cannabis policy depends heavily on who is appointed to key positions in the administration.
  5. International and Domestic Trade:
    • Schedule III status could ease import/export restrictions on cannabis.
    • Unified control of House, Senate, and presidency might expedite legislative progress.
  6. Economic and Industry Impact:
    • Cannabis stocks experienced volatility post-election, reflecting investor uncertainty.
    • Federal legalization and banking reforms are crucial for industry stability and growth.
  7. Future Outlook:
    • The potential for federal rescheduling remains strong, with hearings scheduled for early 2025.
    • State-level initiatives and regulatory developments will continue to shape the industry.

Watch the replay!



Source link

Continue Reading

Cannabis News

I Had Just One Puff

Published

on

By


one puff of a joint a drug test

“How Long Does One Puff of Weed Stay in Your System?”… This topic can be difficult to answer since it is dependent on elements such as the size of the hit and what constitutes a “one hit.” If you take a large bong pull then cough, it might linger in your system for 5-7 days. A moderate dose from a joint can last 3-5 days, whereas a few hits from a vaporizer may last 1-3 days.

 

The length of time that marijuana stays in the body varies based on a number of factors, including metabolism, THC levels, frequency of use, and hydration.

 

Delta-9-tetrahydrocannabinol, or THC, is the primary psychoactive component of cannabis. THC and its metabolites, which remain in your body long after the effects have subsided, are detected by drug tests.

 

Since these metabolites are fat-soluble, they cling to bodily fat molecules. They could thus take a while to fully pass through your system, particularly if your body fat percentage is higher.

 

THC is absorbed by tissues and organs (including the brain, heart, and fat) and converted by the liver into chemicals such as 11-hydroxy-THC and carboxy-THC. Cannabis is eliminated in feces at a rate of around 65%, while urine accounts for 20%. The leftover amount might be kept within the body.

 

THC deposited in bodily tissues ultimately re-enters the circulation and is processed by the liver. For frequent users, THC accumulates in fatty tissues quicker than it can be removed, thus it may be detectable in drug tests for days or weeks following consumption.

 

The detection time varies according to the amount and frequency of cannabis usage. Higher dosages and regular usage result in longer detection times.

 

The type of drug test also affects detection windows. Blood and saliva tests typically detect cannabis metabolites for shorter periods, while urine and hair samples can reveal use for weeks or even months. In some cases, hair tests have detected cannabis use over 90 days after consumption.

 

Detection Windows for Various Cannabis Drug Tests

 

Urine Tests

Among all drug tests, urine testing is the most commonly used method for screening for drug use in an individual.

 

Detection times vary, but a 2017 review suggests the following windows for cannabis in urine after last use:

 

– Single-use (e.g., one joint): up to 3 days

– Moderate use (around 4 times a week): 5–7 days

– Chronic use (daily): 10–15 days

– Chronic heavy use (multiple times daily): over 30 days

 

Blood Tests

Blood tests generally detect recent cannabis use, typically within 2–12 hours after consumption. However, in cases of heavy use, cannabis has been detected up to 30 days later. Chronic heavy use can extend the detection period in the bloodstream.

 

Saliva Tests

THC can enter saliva through secondhand cannabis smoke, but THC metabolites are only present if you’ve personally smoked or ingested cannabis.

 

Saliva testing has a short detection window and can sometimes identify cannabis use on the same day. A 2020 review found that THC was detectable in the saliva of frequent users for up to 72 hours after use, and it may remain in saliva longer than in blood following recent use.

 

In areas where cannabis is illegal, saliva testing is often used for roadside screenings.

 

Hair Tests

Hair follicle tests can detect cannabis use for up to 90 days. After use, cannabinoids reach the hair follicles through small blood vessels and from sebum and sweat surrounding the hair.

 

Hair grows at approximately 0.5 inches per month, so a 1.5-inch segment of hair close to the scalp can reveal cannabis use over the past three months.

 

Factors Affecting THC and Metabolite Retention

 

The length of time THC and its metabolites stay in your system depends on various factors. Some, like body mass index (BMI) and metabolic rate, relate to individual body processing, not the drug itself.

 

Other factors are specific to cannabis use, including:

 

– Dosage: How much you consume

– Frequency: How often you use cannabis

– Method of consumption: Smoking, dabbing, edibles, or sublingual

– THC potency: Higher potency can extend detection time

 

Higher doses and more frequent use generally extend THC retention. Cannabis consumed orally may remain in the system slightly longer than smoked cannabis, and stronger cannabis strains, higher in THC, may also stay detectable for a longer period.

 

How Quickly Do the Effects of Cannabis Set In?

 

When smoking cannabis, effects appear almost immediately, while ingested cannabis may take 1–3 hours to peak.

 

The psychoactive component THC produces a “high” with common effects such as:

 

– Altered senses, including perception of time

– Mood changes

– Difficulty with thinking and problem-solving

– Impaired memory

 

Other short-term effects can include:

– Anxiety and confusion

– Decreased coordination

– Dry mouth and eyes

– Nausea or lightheadedness

– Trouble focusing

– Increased appetite

– Rapid heart rate

– Restlessness and sleepiness

 

In rare cases, high doses may lead to hallucinations, delusions, or acute psychosis.

 

Regular cannabis use may have additional mental and physical effects. While research is ongoing, cannabis use may increase the risk of:

 

– Cognitive issues like memory loss

– Cardiovascular problems including heart disease and stroke

– Respiratory illnesses such as bronchitis or lung infections

– Mood disorders like depression and anxiety

 

Cannabis use during pregnancy can negatively impact fetal growth and development.

 

Duration of Effects

Short-term effects generally taper off within 1–3 hours, but for chronic users, some long-term effects may last days, weeks, or even months. Certain effects may even be permanent.

 

Bottom Line

The amount of time that cannabis remains in your system following a single use varies greatly depending on individual characteristics such as body fat, metabolism, frequency of use, and mode of intake. Frequent users may maintain traces of THC for weeks, whereas infrequent users may test positive for as little as a few days. Hair tests can disclose usage for up to 90 days, while blood and saliva tests identify more recent use. Urine tests are the most popular and have varying detection durations. The duration that THC and its metabolites are detectable will ultimately depend on a number of factors, including dose, strength, and individual body chemistry.

 

PEE IN A CUP COMING UP, READ ON..

how long does weed stay in your urine

HOW LONG DOES WEED STAY IN YOUR URINE FOR A DRUG TEST?



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media